Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
This page covers all Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1.
Targets
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
Marketed (1)
- Corlanor · Amgen · Cardiovascular
Patent intelligence
- hyperpolarization activated cyclic nucleotide gated channel blocker patent landscape — aggregated cliff calendar, attackable patents, originator estates